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Abstract: Bioactive sol-gel glasses are attractive biomaterials from both technological and functional
viewpoints as they require lower processing temperatures compared to their melt-derived counterparts
and exhibit a high specific surface area due to inherent nanoporosity. However, most of these
materials are based on relatively simple binary or ternary oxide systems since the synthesis
of multicomponent glasses via sol-gel still is a challenge. This work reports for the first
time the production and characterization of sol-gel materials based on a six-oxide basic system
(SiO2–P2O5–CaO–MgO–Na2O–K2O). It was shown that calcination played a role in inducing the
formation of crystalline phases, thus generating glass-ceramic materials. The thermal, microstructural
and textural properties, as well as the in vitro bioactivity, of these sol-gel materials were assessed and
compared to those of the melt-derived counterpart glass with the same nominal composition. In spite
of their glass-ceramic nature, these materials retained an excellent apatite-forming ability, which is
key in bone repair applications.
Keywords: bioactive glass; glass-ceramic; biomaterials; bioceramics; sol-gel; bioactivity; porosity;
bone tissue engineering; textural properties; nanomaterials
1. Introduction
Bioactive glasses are commonly considered eligible materials for bone tissue engineering
applications as they are able to promote bone tissue healing [1–3] due to a progressive dissolution
process, which releases into the physiological environment ionic products able to stimulate osteoblastic
activity and, thus, the growth of new tissue [4,5].
As a result, bioactive glasses have been extensively investigated for the treatment of
medium-to-critical sized bone defects deriving from chronical diseases and traumatic events [6–8].
According to the final clinical application, bioactive glasses can be processed in the form of monoliths,
particles and porous three-dimensional (3D) scaffolds mimicking the trabecular bone architecture [9].
However, current clinical approaches for the treatment of small defects in non-bearing anatomical sites
mainly rely on the usage of granules and particles due to a paucity of international rules concerning
the manufacturing and validation processes of bioactive glass-based porous 3D scaffolds [10,11].
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The first use of bioactive glass particles in the clinical practice dates back to 1993, when Hench’s
45S5 Bioglass was marketed under the tradename of PerioGlas for the treatment of periodontal
diseases, with particles diameter in the range of 90–710 µm [9]. Compared to large-size cast products
and monoliths or porous scaffolds obtained from thermal consolidation of glass powder (sintering),
bioactive glass particles generally expose a much higher specific surface area (SSA), which leads to
higher conversion rate into hydroxyapatite: this is key in all those applications where a fast new bone
deposition is required. The strategies commonly adopted to further improve the reaction kinetics of
glasses in the physiological environment rely on the appropriate compositional design, method of
production and additional treatments (e.g., calcination conditions). It is known, for example, that
bioactive glass powders can be produced by both a traditional melt-quenching route and the sol-gel
process [12,13]. Most melt-derived bioactive glasses, however, are affected by a series of limitations.
Melt-quenching requires high temperatures (typically around 1500 ◦C) to allow the melting of the
oxide precursors. Moreover, bioactivity in melt-derived silicate glasses is possible only in a limited
compositional range, as SiO2 amounts higher than 60 mol % make the material almost chemically inert
in contact with body fluids [3].
Compared to the traditional melt-quenching route, the sol-gel process offers the possibility to
obtain more reactive materials in a wider compositional range (up to 90% of SiO2) due to the unique
textural properties (inherent nanoporosity) that directly derive from the synthesis process [14–18].
The 45S5 Bioglass was produced via both melt-quenching [3] and sol-gel routes [19–21] but, to date,
the latter strategy has been seldom applied. In this regard, the first attempt was reported by Chen
and Thouas [19] who first succeeded in introducing Na2O in the sol-gel synthesis of 45S5 bioactive
glass. Later, Cacciotti and coworkers [20] demonstrated that the crystallinity, bioactive mechanism and
reaction kinetics in vitro of sol-gel 45S5 glass can be modulated by appropriate post-synthesis thermal
treatments. In another study, Faure et al. [21] reported the sol-gel synthesis of 45S5 bioactive glass by
using an organic acid as a catalyst. A slight increase of the SSA was observed in the sol-gel material
with respect to the melt-derived counterpart (from 0.4 m2/g to 0.9 m2/g), while the apatite-forming
ability was found to be comparable to that of commercial cast 45S5 Bioglass.
A review of the literature shows that most of the sol-gel glasses belong to binary (SiO2–CaO)
or ternary systems (SiO2–CaO–P2O5) [17,22,23] with high amounts of silica; as discussed above,
the 45S5 composition is one of the very few “quaternary” exceptions [19–21]. Unlike melt-derived
glasses, it is not strictly necessary to include too high of an amount of modifier oxides to lower the
processing temperature of gel-derived glasses since the formation of the glass network occurs at room
temperature [9]. However, some additional elements are highly beneficial for tailoring the bioactive
and even biological response of the material (therapeutic effect). For example, CaO and MgO were
reported to play an important role in surface reaction kinetics, new bone formation and bone cell
adhesion and stability [24–26]. Silver was also incorporated in sol-gel SiO2–CaO glasses to obtain
foam-like scaffolds with antibacterial properties [27].
In this work, we applied, for the first time, the sol-gel process to synthesize bioactive materials
based on a complex six-oxide system. The parent SiO2–P2O5–CaO–MgO–Na2O–K2O composition
was previously designed and investigated by our research group to produce a melt-derived glass
(47.5B) [28,29], which was particularly appreciated because of its wide workability window and
bioactive properties. Apart from innovatively describing the synthesis of this multicomponent glass
by the sol-gel method, the present work also is one of the few available studies reporting a direct
comparison between melt-derived and sol-gel materials with the same nominal composition.
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2. Materials and Methods
2.1. Production of Glass and Glass-Ceramic Materials
2.1.1. Melt-Quenching Route
A 47.5B bioactive silicate glass with composition 47.5SiO2–20CaO–10MgO–2.5P2O5–10K2O–10Na2O
(mol %) was produced by the traditional melt-quenching route as previously described by Fiume
et al. [30]. Briefly, a blend of oxides and carbonates was heated in a capped platinum crucible up
to 1000 ◦C (heating rate 12 ◦C/min) to allow the thermal decomposition of glass precursors. After
that, the crucible cap was removed and the temperature inside the furnace was increased to 1500 ◦C
(heating rate 15 ◦C/min). After 30 min, the melt was poured into distilled water to obtain a glass frit
which was then left to dry at room temperature for 24 h. Glass powders were obtained by ball milling
(Pulverisette 0, Fritsch, Idar-Oberstein, Germany) and sifted (stainless steel sieve, Giuliani Technology
Srl, Turin, Italy) in order to get a final particle size below 32 µm. Melt-derived 47.5B bioactive glass,
hereafter named MD-47.5B, was used as a control in the present study.
2.1.2. Sol-Gel Synthesis
Multicomponent materials based on the six-oxide system 47.5SiO2–20CaO–10MgO–2.5P2O5–
10K2O–10Na2O (mol %) were produced by the sol-gel process for the first time. Tetraethyl orthosilicate
(TEOS), tri-ethyl phosphate (TEP), calcium nitrate tetrahydrate (Ca(NO3)2·4H2O), sodium nitrate
(NaNO3), magnesium nitrate hexahydrate ((MgNO3)2·6H2O) and potassium nitrate (KNO3) were used
as SiO2, P2O5, CaO, Na2O, MgO and K2O sources, respectively. A solution comprising 10 mL HNO3
(2N) and 60 mL distilled water was mixed in sealed flasks for 5 min at room temperature; the acid
served as a catalyst for the subsequent hydrolysis of TEOS. Afterward, TEOS was added to the solution
that was mixed under continuous magnetic stirring (200 rpm) for 15 min. An H2O:TEOS molar ratio of
20 was used in good accordance with the study reported by Bahniuk et al. [31]. All the other reagents
were then sequentially added to the batch, which was mixed for 45 min until a clear and homogeneous
sol was obtained.
Gelation was carried out at room temperature for 72 h. After that, samples were aged for 72 h in
an oven at 60 ◦C. The treatment was performed by maintaining the flasks sealed in order to prevent
the dispersion of volatile components. For the drying treatment, the flasks were slightly opened to
allow the slow evaporation of the alcoholic liquid phase while the temperature was increased up to
120 ◦C (48 h).
In order to follow the evolution of the material, part of the dried gel was milled and stored in a
drier closet to avoid moisture absorption (sample DG-120), while the remaining one was calcined up to
625 ◦C (Ts1) (sample SG-625) or 800 ◦C (Ts2) (sample SG-800), following the two heating programs
displayed in Figure 1. The calcined materials (SG-625 and SG-800) were then ball milled and sieved
(mesh 32 µm), as previously described for the MD-47.B system.
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Figure 1. Heating programs used for the calcination of DG-120 at Ts1 = 625 ◦C (a) and Ts2 = 800 ◦C
(b). Intermediate dwelling times and final calcination temperatures were identified on the basis of the
differential thermal analysis results.
2.2. Materials Characterizations
2.2.1. Thermal Analyses
Differential thermal analysis (DTA; DTA404PC, Netzsch, Selb, Selb, Germany) was performed on
MD-47.5B and DG-120 samples to investigate and compare the thermal behaviors of both materials,
which had the same nominal oxide composition but were produced by melting or the sol-gel process;
specifically, glass transition temperature (Tg), crystallization onset temperature (Tx) and maximum
rate of crystallization temperature (Tc). Furthermore, this analysis was useful to select the calcination
temperatures of sol-gel DG-120. For the analysis, MD-47.5B and DG-120 powders (50 mg) were
heated up to 1200 ◦C (heating rate of 10 ◦C/min) in platinum crucibles, using high-purity Al2O3
alumina powder as reference material. Under the same conditions and using the same equipment,
thermogravimetric analysis (TGA) was concurrently performed on DG-120 to quantify the mass loss of
the material upon heating.
The analysis of the DTA plots was carried out according to the following criteria:
- Tg was identified at the inflection point, as obtained from the first derivative of the plot;
- Peaks in the positive verse of the y-axis (maxima) were associated to exothermal reactions, while
peaks in the negative verse of the y-axis (minima) were attributed to endothermal reactions.
2.2.2. X-Ray Diffraction (XRD)
X-ray diffraction analysis (XRD; X’Pert Pro PW3040/60 diffractometer, PANalytical, Eindhoven,
Netherlands) was performed on MD-47.5B, DG-120, SG-625 and SG-800 powders to assess the
microstructural features of the various materials and identify the presence of crystalline phases
deriving from the thermal treatment. The analysis was performed using a Bragg–Brentano camera
geometry with a Cu Kα incident radiation (wavelength λ = 0.15405 nm). The 2θ angle was varied in a
range of 10◦–70◦; voltage and current were fixed at 40 kV and 30 mA, respectively. Step counting time
for data acquisition was set at 1 s with a step size of 0.02◦. Powder size for SG-625 and SG-800 was
below 32 µm. Crystalline phases were identified by using X’Pert HighScore software 2.2b (PANalytical,
Eindhoven, The Netherlands) equipped with the PCPDFWIN database.
2.2.3. Pore Analysis
Nitrogen (N2) adsorption–desorption porosimetry (ASAP2020 Micromeritics, Norcross, GA, USA)
was used to evaluate and compare the textural properties of the materials and to identify possible
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effects of the synthesis method. The SSA was assessed by applying the Brunauer–Emmett–Teller (BET)
theory [32].
2.2.4. In Vitro Bioactivity Tests
The apatite-forming ability of MD-47.5B, SG-625 and SG-800 powders was investigated by soaking
the materials powders in a simulated body fluid (SBF, pH = 7.40 at body temperature), which was
prepared following the protocol proposed by Kokubo and Takadama in 2006 [33].
A mass-to-volume (powder/SBF) ratio of 1.5 mg/mL was used, according to a previous study
reported by the Technical Committee 4 (TC04) of the International Commission on Glass (ICG) [34].
In vitro bioactivity tests were performed at 37 ◦C in an orbital shaker incubator (IKA 3510001 KS 4000
I Control Incubator Shaker, IKA-Werke GmbH & Co. KG, Staufen, Germany), keeping constant the
shaking speed at 100 rpm.
The pH was monitored at specific time points (6 h, 24 h, 48 h, 72 h, 168 h and 336 h) at 37.0 ± 0.01
◦C in order to qualitatively evaluate the ion exchange between the material surface and the solution on
the basis of the pH variations observed.
At the end of the experiment, the test tubes containing powders and SBF were placed into a
centrifuge (Hermle Z306 Universal Certrifuge, Benchmark Scientific Inc., Edison, NJ, USA) to allow
powders to decant at the bottom of the tube. Afterward, the SBF was completely removed by a syringe
and the powders were rinsed with bi-distilled water. After water removal, the powders were left to
dry at 37 ◦C in static conditions for 48 h. Once dried, the powders were stored into sealed plastic tubes
(Eppendorf, Hamburg, Germany) before undergoing morphological and compositional evaluation.
2.2.5. Morphological and Compositional Investigations
The morphology and composition of samples before (DG-120, SG-625 and SG-800) and after
in vitro bioactivity tests (MD-47.5B, SG-625 and SG-800) were investigated by scanning electron
microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS) (field-emission SEM equipped with
EDS; SupraTM 40, Zeiss, Oberkochen, Germany) in order to evaluate the surface evolution occurring as
a result of the reaction process between the material and the solution upon soaking. For the analysis,
powders were fixed onto a carbon adhesive tape and sputter-coated with a thin layer of chromium
(7 nm). The inspection voltage was set at 15 kV.
3. Results and Discussion
MD-47.5B is a silica-based bioactive glass previously designed and characterized by our research
group. The high amount of modifier oxides, along with the high Ca/P ratio, make this glass very
reactive in the physiological environment and confer to the system an exceptional apatite-forming
ability, which was demonstrated for both powders and 3D porous scaffolds [28,30,35,36]. Moreover,
this melt-derived glass exhibits a wide workability window, which makes it an optimal candidate for
scaffold manufacturing: in fact, it is possible to produce highly densified macroporous structures upon
sintering at a wide temperature range without affecting the reactivity of the material [29].
The present study compares the MD-47.5B system with two properly designed sol-gel materials
having the same nominal composition in order to evaluate the effect of the synthesis route on the
bioactivity and the textural properties of the material.
The DTA thermograph of MD-47.5B (Figure 2a) revealed the characteristic features of glass. Tg, Tx
and Tc were identified at 550, 700 and 750 ◦C, respectively. Consistently to what observed in a previous
report, the wide (Tx – Tg) window of this glass (about 150 ◦C) allows the sintering to be performed
without inducing any crystallization in the amorphous matrix [35]. This aspect is a clear advantage for
scaffold manufacturing, as it allows mechanically resistant struts to be obtained while preserving the
amorphous nature of the material and, thus, its bioactive potential in contact with body fluids.
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Figure 2. Thermal analysis results: DTA plot of MD-47.5B bioactive glass (a) and DTA-TGA plots of
DG-120 sol-gel material before calcination, revealing a multi-peak trend and mass loss up to 800 ◦C (b).
As regards to the sol-gel-derived material, DTA and TGA were performed on the gel DG-120 in
order to identify the most suitable calcination temperature for the final heating treatment (Figure 2b).
The total mass loss up to 800 ◦C, assessed by TGA analysis, was about 50 wt %. It was possible
to attribute most of the mass reduction to two different events, identified at about 110 and 580 ◦C,
related to (i) the evaporation of residual water in the gel and (ii) the thermal decomposition of organic
compounds and nitrates used as oxide precursors in the synthesis process, respectively. With respect to
what was observed in the case of sol-gel 45S5 glass by Cacciotti et al. [20], who reported an endothermic
peak associated to the decomposition of nitrates at 529 ◦C, our thermograph revealed a shift of the
endothermic peak toward higher temperatures (from 529 to 580 ◦C). This can be attributable both to
the higher complexity exhibited by 47.5B composition (compared to 45S5 system) and to the different
heating rates used in the present study for thermal analyses. The exothermic peak at about 680 ◦C
corresponds to the crystallization of combeite, as already confirmed by XRD analysis (this phase was
detected in SG-800 but was not present in the SG-625). The endothermic peaks at about 712 and 755 ◦C
can be attributed to further stages of the thermal decomposition of nitrates, especially sodium nitrate,
as reported by Zheng et al. [37].
Unlike MD-47.5B, it was not possible to define a clear workability window (Tx – Tg) and we
decided to select two different calcination temperatures, Ts1 (625 ◦C) and Ts2 (800 ◦C), according to the
following criteria:
- Ts1 was chosen as the lowest calcination temperature able to ensure thermal decomposition of
most nitrates and other organic compounds according to previous literature; this temperature
was also below the crystallization temperature (exothermic peak centered at about 680 ◦C) and
was very close to that used to sinter MD-47.5B products in previous works (600 ◦C) [35];
- Ts2 corresponds to the maximum mass loss of the system and, thus, to the complete thermal
stabilization of the material before reaching the melting temperature.
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The XRD pattern of MD-47.5B was previously reported by Fiume et al. [30]. It was characterized
by an amorphous halo between 25◦ and 35◦, which is typical of glassy silicate systems. Figure 3
shows the XRD patterns of the gel-derived materials at different stages of the synthesis process. The
DG-120 XRD pattern (Figure 3a) revealed the presence of NaNO3, deriving from the precursor of Na2O
introduced in the sol-gel process. This result was consistent with DTA curve interpretation, as the
drying stage was performed at too low of a temperature (120 ◦C) to allow the thermal decomposition
of nitrates in the gel.
Figure 3. XRD pattern evolution upon thermal treatment of sol-gel 47.5B system at different stages of
the synthesis process: DG-120 (a), SG-625 (b) and SG-800 (c).
Unlike MD-47.5B that was amorphous, SG-625 and SG-800 exhibited a certain crystallinity after
calcination, as confirmed by XRD patterns reported in Figure 3b,c. The XRD pattern of SG-625 shows
the typical appearance of a glass-ceramic material, where an amorphous halo centered between 25◦
and 35◦ is still clearly visible along with some diffraction peaks attributable to nitrates. Persistence of
nitrates at 625 ◦C is consistent with both the DTA analysis (Figure 2b) and with the previous results
reported by Zheng et al. [37], who detected the presence of NaNO3 in sol-gel 45S5 glass-ceramic after
thermal stabilization at 700 ◦C. The XRD pattern of SG-800 exhibits sharp diffraction peaks indicating
the clear development of multiple crystalline phases upon calcination.
The list of all the crystalline phases detected in SG-625 and SG-800, along with reference codes,
formulas and crystal systems, are summarized in Table 1.
Table 1. Crystalline phases detected in SG-625 and SG-800 sol-gel materials.
Detected in: Phase Name Reference Code Formula Crystal System
SG-625
Niter 01-071-1558 KNO3 Orthorhombic
Nitratine 00-036-1474 NaNO3 Rhombohedral
SG-800
Sodium calcium silicate (combeite-type) 01-077-2189 Na2CaSi2O6 Rhombohedral
Potassium magnesium silicate 00-048-0900 K2MgSiO4 Orthorhombic
Rhenanite 00-029-1193 NaCaPO4 Orthorhombic
Interestingly, the major crystalline phase detected in SG-800 is the same (combeite-type
Na2CaSi2O6) that was found by many researchers in the melt-derived 45S5 Bioglass® after
sinter-crystallization above 600 ◦C [38,39]. Sodium calcium silicate crystals (Na2Ca2Si3O9) were
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detected in MD-47.5B sintered at 750 ◦C [30], too, but this combeite-type phase was different compared
to that observed in calcined SG-800.
SEM morphological analyses of DG-120, SG-625 and SG-800 are shown in Figure 4 at different
magnifications. Coarser granules (above 100 µm) were observed for the as-dried gel (DG-120),
compared to the calcined sol-gel materials SG-625 and SG-800, as shown in Figure 4a–c. This was
mainly due to the impossibility of effectively sieving the gel granules because of their high hygroscopic
behavior and tendency to form aggregates. At higher magnification (Figure 4c), an ordered tile-like
structure was observed. Finer particles with qualitatively more uniform size were observed for SG-625
and SG-800 as a direct result of the sieving process. In both cases, smaller particles tended to form
aggregates on the surface of bigger ones, as clearly shown in Figure 4e,h.
Figure 4. SEM morphological evaluation of DG-120 (a–c), SG-625 (d–f) and SG-800 (g–i) sol-gel-derived
powders at different magnifications.
Consistently with the DTA and XRD results, EDS analysis performed on the as-dried gel and
SG-625 (Figure 5a,b) confirmed the presence of nitrogen in the material composition deriving from the
synthesis precursors, as a direct result of the low temperature used for the calcination process, while
no nitrogen was detected in the glass-ceramic calcined at 800 ◦C (Figure 5c).
Figure 5. EDS compositional analysis performed on DG-120 (a), SG-625 (b) and SG-800 (c) sol-gel materials.
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The BET results are summarized in Table 2. SG-625 and SG-800 exhibited higher SSA compared to
MD-47.5B, which confirms the role played by the synthesis process (sol-gel vs. melt-quenching) on the
textural properties of materials. The SSA tends to decrease by a factor 2 if the calcination temperature
is increased from 625 to 800 ◦C because the materials nanoporosity—which is inherent of the sol-gel
process—is reduced accordingly. A similar trend was observed for the pore volume, too. In general,
the values of SSA of SG-625 and SG-800 are remarkably lower (from one to two orders of magnitude)
than those observed in other silicate sol-gel biomaterials [14,40,41]: this might be attributed to the
complex composition of the six-oxide system produced as well as to the development of crystalline
phases, but further studies are required to better investigate this peculiar aspect in the future. Total
pore volume values related to the three materials are consistent with the results discussed above.
Table 2. Brunauer–Emmett–Teller (BET) analysis results.
Material Class Calcination Temperature (◦C) SSA (m2/g) Pore Volume (cm3/g)
MD-47.5B Glass As-quenched 0.6379 0.001304
SG-625 Glass-ceramic 625 2.2330 0.016708
SG-800 Glass-ceramic 800 1.2307 0.002727
The pH increase due to ion exchange between the materials and the solution upon in vitro
bioactivity tests in SBF is plotted in Figure 6. Although no statistically significant differences were
observed for the three systems, some observations could be made:
Figure 6. In vitro bioactivity tests: pH increase as a function of the soaking time in simulated body
fluid (SBF).
- The system showing the highest value of SSA was the one for which the highest pH increase was
observed (i.e., SG-625), thereby suggesting a direct correlation between SSA and reactivity of the
material in aqueous solution—in other words, the higher the SSA, higher the reactivity;
- For SG-625 glass-ceramic, the pH value stabilized after 48 h immersion with the achievement of a
plateau at around 7.95, while a continuous increase up to two weeks was observed in the case of
MD-47.5B and SG-800. This may suggest that most of the in vitro bioactivity reactions of SG-625
took place within two days from the beginning of the test; afterward, a chemical equilibrium
was reached;
- SG-800- and MD-47.5B-related curves were comparable both in trends and in pH values, suggesting
comparable reaction rates of the materials in SBF.
A moderate increase of pH (<8.0) toward alkalinity, like in the present case, is beneficial to
osteoblasts [42]. On the contrary, other sol-gel bioactive materials reveal a tendency to markedly
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increase the pH of surrounding fluids due to high reactivity in SBF. In this regard, thermal treatment
and, hence, crystallinity can play a role: for example, gel-derived 45S5 glass thermally treated at
700 ◦C led to a pH above 9.5 after seven days in SBF, while the same material calcined at 1100 ◦C
(glass-ceramic) exhibited a lower reactivity (pH around 8.5 at one week) [20].
SEM morphological analyses after bioactivity tests in SBF (Figure 7) revealed an excellent
apatite-forming ability of both melt-derived and sol-gel 47.5B-based materials, regardless of the
production route used and calcination temperature. Calcium phosphate globular agglomerates were
observed on the surface of MD-47.5B glass after just 48 h of soaking, confirming the high bioactivity of
the positive control used in the present study.
Figure 7. In vitro bioactivity tests: SEM analysis showing the surface evolution at different immersion
time periods in SBF.
After a two-day immersion in SBF, apatite-like structures were observed to form also on the
surface of SG-625 and SG-800 glass-ceramics. A quite uniform, thin layer was observed on SG-800,
while larger calcium phosphate agglomerates formed on SG-625. Despite the presence of crystalline
phases in both sol-gel materials, the bioactivity mechanism was not inhibited. Nanopores in the range
of 50–100 nm were observed on the surface of SG-625, suggesting a correlation between SSA values
and this nanostructured feature.
After a two-week immersion in SBF, calcium phosphate coatings formed by nanostructured
globular agglomerates, the morphology of which closely resembles that of hydroxyapatite, were
observed on the surface of all the samples.
EDS measurements proved a progressive deposition of calcium and phosphorus on the surface of
the materials. At the end of the test, atomic Ca/P ratios for MD-47.5B, SG-625 and SG-800 were 1.65,
1.63 and 1.48, respectively (average calculated on five sites per sample). The Ca/P ratios of MD-47.5B
and SG-625 were quite close to that of stoichiometric hydroxyapatite (Ca/P = 1.67).
The formation of a hydroxyapatite layer in SBF is commonly recognized as the criterion to estimate
the bioactive potential of (bio)materials. However, the relationship between in vitro results and in vivo
behavior has been debated in the last decade. Kokubo and Takadama [33] reported convincing evidence
that hydroxyapatite formation on the surface of a given material in SBF can actually be predictive of
its bioactivity in vivo (i.e., bone-bonding ability). On the contrary, Bohner and Lamaitre [43] showed
that this approach may be questionable due to some important limitations and there is still room
for improvement. Currently, the scientific community recognizes the importance of in vitro tests in
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“inorganic” SBF to obtain a preliminary indication about bioactivity, although being aware that in vitro
conditions can only roughly match those in the human body.
The formation of a hydroxyapatite layer on the surface of partially crystalline materials derived
from a parent bioactive glass is not so obvious as devitrification can decrease bioactivity, as clearly
demonstrated for melt-derived glass-ceramics in the SiO2–Na2O–CaO–P2O5 system [44]. The majority
of bioactive silicate materials produced by the sol-gel route are in a glassy state; furthermore, it was
shown that sol-gel glass-ceramics based on the 45S5 or 70S30C (70SiO2–30CaO mol %) systems retain a
good apatite-forming ability regardless of the formation of crystalline phases [45]. The results achieved
in the present work are consistent with these previous ones: the apatite-forming ability could be further
improved in a future study by introducing a structure-directing agent in the sol-gel process (as already
reported for simpler compositional systems [46]) to obtain mesoporous materials with ultrahigh SSA
and, hence, higher reactivity.
4. Conclusions
Silicate materials with complex compositions based on a six-oxide system (47.5B) were successfully
synthesized, for the first time, by the sol-gel route. Interestingly, while the melt-derived counterpart
was fully amorphous, calcined sol-gel products are glass-ceramic. The complexity of the composition
played a role in this regard as conventional binary or ternary sol-gel glasses are known to be typically
amorphous. The method of production has a clear effect on the textural properties, as the SSA of sol-gel
47.5B-based materials was from two to four times higher than that of melt-derived glass. However, the
SSA values of sol-gel 47.5B-based materials were drastically lower than those detected in sol-gel glasses
with simpler formulation (few m2/g vs. tens/hundreds of m2/g); specifically, an increase of calcination
temperature was associated to a decrease of SSA. Interestingly, sol-gel 47.5B-based glass-ceramics
still exhibited a promising bioactive potential regardless of the formation of crystalline phases, the
presence of which, instead, is often associated with a dramatic decrease of apatite-forming ability in
melt-derived materials. In the future, in vitro studies with appropriate cell lines will be carried out in
order to assess the cytocompatibility of the materials here investigated.
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